Brii Biosciences Limited
- Biotech or pharma, therapeutic R&D
Brii Biosciences is a clinical stage biotech company with multiple Phase 2 studies on-going in hepatitis B viral infection (HBV). Our drug discovery strategy is centered on combining our internal drug discovery and development expertise in liver diseases with contemporary platform modalities to find medicines for high unmet need disease areas. With a strong balance sheet of over $300 million cash, we are interested in acquiring or in-licensing early stage innovative assets to enrich our pipeline. We are also open to partnership on our in-house discovered programs for further development.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}